Biomedicare ApS: Financial statements 2025
CVR: 16211508
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biomedicare ApS (CVR 16211508) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 38 compared with DKK 187,625 the year before. Equity in the 2025 report amounted to DKK 53,267. The solvency ratio was 100%.
- Profit/Loss
- DKK 38
- Equity
- DKK 53,267
- Total Assets
- DKK 53,267
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 38 | 53K | - |
| 2024 | 188K | 188K | 188K | 53K | - |
| 2023 | - | 180K | 180K | -134K | - |
| 2022 | 0 | 0 | 0 | -314K | - |
| 2021 | 0 | 0 | 0 | -314K | - |
Official annual report
How creditworthy is Biomedicare ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Biomedicare ApS has published its annual report for 2024. Revenue came to DKK 187,500, and the net result was DKK 187,625.
About Biomedicare ApS
Biomedicare ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1992. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The company was previously named KAROLINE CHARTER ApS. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a net result of DKK 38 compared with DKK 187,625 the year before. Equity in the 2025 report amounted to DKK 53,267.
